Celfinet has been acquired by the Indian listed multinational Cyient
The private shareholdersof Celfinet, a Portuguese IT Engineering company, have sold the company to Cyient.
Celfinet is a wireless engineering services company focused on providing end-to-end network planning and performance optimization services. Celfinet has successfully built an international business combining outstanding wireless engineering expertise and a best-in-class network management solutions portfolio to improve network quality and customer experience. The company is a trusted technology partner to some of the world’s leading mobile operators.
Cyient, a multinational enterprise listed on the National Stock Exchange of India, is a leading global engineering, manufacturing and digital technology solutions company. Cyient has more than 300 customers and a global footprint in 19 countries.
Oaklins’ team in Portugal acted as the exclusive M&A advisor to the shareholders of Celfinet. The team was involved throughout the preparation of the sale process and supported all aspects of the negotiation phase until closing.
Nuno Ribeiro and José Mata
CEO and Founder & Co-CEO, Celfinet
Talk to the deal team
Related deals
TEAM Safety Services Limited has been acquired by Vadella Group
TEAM Safety Services Limited, a leading UK-based health, safety and fire safety consultancy, has been acquired by Vadella Group, a specialist provider of inspection-led compliance services for the built environment.
Learn moreNiscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Learn moreBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Learn more